isak55 / shutterstock.com
The IP Life Sciences Exchange, an event for senior IP decision-makers from the life sciences sector, will take place on November 15 and 16 in Munich, Germany. LSIPR previews some of the most interesting sessions.
Session: Strategic steps to take in the wake of uncertain patent eligibility across biopharma
When: 12:45–13:15, November 15
This session kicks off with speakers representing the European Commission, and biotechnology companies Sotio and New England Biolabs. In this session, speakers will assess why it is important to have predictability and uniformity in the global biotech IP sector.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
IP Life Sciences Exchange, Munich, medicine, patent, infringement, Brexit, biopharma